Renin-angiotensin-aldosterone system blockers as the main pathogenetic approach of drug nephroprotection
Journal Title: Нирки - Year 2019, Vol 8, Issue 1
Abstract
The paper considers the modern trends in the therapy of nephrologic pathology with nosotropic justification of the predominant role of renin-angiotensin-aldosterone system (RAAS) blockers in modern nephroprotection. The attention is paid to the fact that the pathogenesis of kidney diseases is inevitably associated with the state of RAAS, whose adaptive and compensatory possibilities are naturally changing for pathologic activation and direct involvement, namely, angiotensin II, the main effector molecule, in the structural and functional rebuilding of the kidneys. Pathogenetic therapy is virtually always directed at secondary etiology links, therefore, the modulation of the RAAS state is practically obligatory and is always an effective approach to nephroprotection. Accordingly, suppression of excessive neurohumoral effects at different levels of RAAS is practically relevant, pathogenetically justified mechanism for the preservation of functional nephrons. Administration of drugs with different pharmacodynamic properties depends on the correct selection of patients’ population, the success of therapy — on the adequate selection of RAAS blockers taking into account the clinical situation and their combination with nephroprotectors of other pharmacological classes.
Authors and Affiliations
N. D. Filipets, D. D. Ivanov, A. I. Gozhenko
Keywords
Related Articles
- EP ID EP473994
- DOI 10.22141/2307-1257.8.1.2019.157794
- Views 63
- Downloads 0
Predictors of chronic heart failure development and progression in pre-dialysis patients with chronic kidney disease
Chronic kidney disease leads to early damage to the heart and blood vessels with the development of heart failure. The manifestation of one disease leads to the progression of another, since chronic heart failure is a co...
Symposium 172 "Urinary Tract Infections"
Urinary tract infections are one of the largest groups of renal diseases. They occupy a leading place among the human organism infections in general. The main topics of discussion are the classification, etiological fact...
Do We Need a Diet Therapy to Manage Patients with Chronic Kidney Disease in the Predialysis Period?
The article examines the criteria for diagnosis of chronic kidney disease and the feasibility of diet therapy in combination with keto-analogues of essential amino acids at predialysis stage. It is proved that additional...
Comparative evaluation of uricodepressants allopurinol and febuxostat in gouty nephropathy. Message 2. Еxperimental study
Background. In our previous study (message 1), a comparative evaluation on the efficacy of two uricodepressants, allopurinol and febuxostat, was performed in terms of their effect on the functional state of the kidneys i...
Proteomics and Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging as a Modern Diagnostic Tool in Kidney Diseases
As a result of the rapid evolution of modern science, we are continually improving our knowledge of disease pathogenesis and morphology on a daily basis. Due to the era of omics sciences, such as genomics, transcriptomic...